Demant A/S : FY due 8 February – Driven by More
>Preview - We expect FY 2021 revenues of DKK 18,156m for Demant (+25.5% y-o-y, 2% below consensus), driven by organic growth of 26.2% and external growth of 150bp, while FX is likely to create a headwind of 220bp. We expect hearing aids to benefit from a strong showing by the well-performing Oticon More platform, while hearing care should continue to recover nicely and has experienced a tailwind from the French reform. We see diagnostic instruments being pushed by a r...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.